Pharmaceutical

Shionogi Announces Supplemental Approval in Japan for Pediatric Dosage and Administration of XOCOVA to Treat COVID-19

Shionogi Announces Supplemental Approval in Japan for Pediatric Dosage and Administration of XOCOVA to Treat COVID-19

articleShionogi & Co., Ltd.June 19, 20263/news/shionogi-announces-supplemental-approval-in-japan-for-pediatric-dosage-and-administration-of-xocova-to-treat-covid-19
Shionogi Announces Supplemental Approval in Japan for Pediatric Dosage and Administration of XOCOVA to Treat COVID-19

About this update from Shionogi & Co., Ltd.

Shionogi & Co., Ltd. (4507) Press ReleaseView Attachment

View stock analysis, news, and events for Shionogi & Co., Ltd.